1 Followers on Owler
OverviewCompetitorsNews & Insights

Rafarma Pharmaceuticals Competitors or Alternatives

Rafarma Pharmaceuticals's top competitors include Trusted Tablets, High Times and Ubiquiti.

Unlock 12 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • CEO

    CEO RATING

    EMPLOYEES

  • FUNDING

    REVENUE

  • CEO

    CEO RATING

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Rafarma Pharmaceuticals's company profile

CEO

- -
1 - 25
$0
$5M - 25M

  • CEO

    - -
    1 - 25
  • $0
    $5M - 25M

  • CEO

    - -
  • 1 - 25
    $0
  • $5M - 25M

  • CEO

  • - -
  • 1 - 25
  • $0
  • $5M - 25M
View ProfileView
1
Rafarma Pharmaceuticals's Competitor - Trusted Tablets logo

CEO

- -
25 - 100
- -
$5M - 25M

  • CEO

    - -
    25 - 100
  • - -
    $5M - 25M

  • CEO

    - -
  • 25 - 100
    - -
  • $5M - 25M

  • CEO

  • - -
  • 25 - 100
  • - -
  • $5M - 25M
View ProfileView
2
Rafarma Pharmaceuticals's Competitor - High Times logo

Peter Horvath

CEO

55/100
25 - 100
$10M
$5M - 25M

  • Peter Horvath

    CEO

    55/100
    25 - 100
  • $10M
    $5M - 25M

  • Peter Horvath

    CEO

    55/100
  • 25 - 100
    $10M
  • $5M - 25M

  • Peter Horvath

    CEO

  • 55/100
  • 25 - 100
  • $10M
  • $5M - 25M
View ProfileView
3
Rafarma Pharmaceuticals's Competitor - Ubiquiti logo

Robert J. Pera

Chairman & CEO

46/100
1,380
$105.6M
$1.8B

  • Robert J. Pera

    Chairman & CEO

    46/100
    1,380
  • $105.6M
    $1.8B

  • Robert J. Pera

    Chairman & CEO

    46/100
  • 1,380
    $105.6M
  • $1.8B

  • Robert J. Pera

    Chairman & CEO

  • 46/100
  • 1,380
  • $105.6M
  • $1.8B
View ProfileView
4
Rafarma Pharmaceuticals's Competitor - AltMed logo

John Tipton

CEO

84/100
250 - 500
$35.4M
$25M - 100M

  • John Tipton

    CEO

    84/100
    250 - 500
  • $35.4M
    $25M - 100M

  • John Tipton

    CEO

    84/100
  • 250 - 500
    $35.4M
  • $25M - 100M

  • John Tipton

    CEO

  • 84/100
  • 250 - 500
  • $35.4M
  • $25M - 100M
View ProfileView
5
Rafarma Pharmaceuticals's Competitor - Lilly logo

David A. Ricks

Chairman & CEO

93/100
35,000
- -
$29.2B

  • David A. Ricks

    Chairman & CEO

    93/100
    35,000
  • - -
    $29.2B

  • David A. Ricks

    Chairman & CEO

    93/100
  • 35,000
    - -
  • $29.2B

  • David A. Ricks

    Chairman & CEO

  • 93/100
  • 35,000
  • - -
  • $29.2B
View ProfileView
Rafarma Pharmaceuticals' top 15 competitors are Trusted Tablets, High Times, Ubiquiti, Vicore Pharma, AltMed, Lilly, Ability Pharma, Abbott, Cipla, BMS, Trustpilot, Lilly Oncology, YGvtc, Cambium Networks and 420 Magazine. Together they have raised over 464.1M between their estimated 209.3K employees. Rafarma Pharmaceuticals's revenue is the ranked 10th among it's top 10 competitors. The top 10 competitors average 7.9B. Rafarma Pharmaceuticals has 10 employees and is ranked 15th among it's top 10 competitors. The top 10 competitors average 13,080.

Trusted Tablets is a top competitor of Rafarma Pharmaceuticals. Trusted Tablets was founded in Larnaca, Larnarca District} in 2007. Trusted Tablets competes in the industry. Compared to Rafarma Pharmaceuticals, Trusted Tablets generates $4.4M less revenue.

High Times is Rafarma Pharmaceuticals's #2 competitor. High Times is headquartered in Los Angeles, California, and was founded in 1974. High Times operates in the industry. High Times generates 147% the revenue of Rafarma Pharmaceuticals.

Ubiquiti has been one of Rafarma Pharmaceuticals's top competitors. Ubiquiti is a Public company that was founded in 2003 in New York, New York. Ubiquiti operates in the industry. Compared to Rafarma Pharmaceuticals, Ubiquiti has 1,370 more employees.

Trending News for Rafarma Pharmaceuticals and Rafarma Pharmaceuticals's Competitors

February 3, 2023MarketScreener
(marketscreener.com) ~ Revenues of $493.6 million ~ ~ GAAP Diluted Earnings Per Share of $1.86 ~https://www.marketscreener.com/quote/stock/UBIQUITI-INC...
February 3, 2023Pharmabiz
Cipla, a Rs. 21,600 crore plus pharma major, has posted single digit growth in revenues as well as profits during the third quarter ended December 2022...
February 3, 2023MarketScreener
(marketscreener.com) Bristol Myers Squibb today announced that the company will take part in a fireside chat at the Guggenheim Healthcare Talks 2023 On...

Frequently Asked Questions about Rafarma Pharmaceuticals

  1. Who are Rafarma Pharmaceuticals's top competitors?

    Rafarma Pharmaceuticals's top 3 competitors are Trusted Tablets, High Times, Ubiquiti.

  2. Who is similar to Rafarma Pharmaceuticals?

    Trusted Tablets is the most similar to Rafarma Pharmaceuticals. High Times and Ubiquiti are also similar to Rafarma Pharmaceuticals.

  1. Are Rafarma Pharmaceuticals and Trusted Tablets competitors?

    Yes, Trusted Tablets is one of Rafarma Pharmaceuticals’s top competitors.